KCHRS Highlights 2013

CRT Non-Responders: Causes and Management - James Daubert – Duke University Medical Center
AF and Dementia can Dementia be Prevented in AF Patients - John Day – Intermountain Heart Institute
Who is the Right Candidate for CRT? The Patient Selection Conundrum - Niraj Varma – Cleveland Clinic
KU Pioneer in Cardiovascular Electrophysiology Award – Albert Waldo – Case Western Reserve University
State of the Art in Heart Rhythm Monitoring - Rhea Pimentel – University of Kansas Medical Center
Don’t get fried in the EP Lab: Advances in Radiation Reduction - Dhanunjaya Lakkireddy — University of Kansas Medical Center
New Directions in Antiarrhythmic Drugs for Rhythm Control in Atrial Fibrillation — Untying a Gordian Knot - Sanjeev Saksena—Robert Wood Johnson University Hospital
MRI and Cardiac Devices - Samuel Asirvatham – Mayo Clinic
Role of Genetic Testing for Electrical and Structural Cardiomyopathies: Are we there yet? - Abraham Kockeril – University of Illinois
Understanding Lead and Cardiac Device Failure and Appropriate Management Strategies - Madhu Reddy — University of Kansas Medical Center
Understanding bleeding and stroke risk in patients with Atrial Fibrillation - Anne Gillis – University of Calgary

Content Unavailable

We apologize this content is not available at this time.

Systemic Anticoagulation – How do you select which drug for whom? - Sana Al-Khatib – Duke University Medical Center
Left Atrial Appendage Exclusion for Stroke Prophylaxis – State of the art field - Andrea Natale – Texas Cardiac Arrhythmia Institute
Renal Denervation for Treatment of BP, CHF, AF and VT - Douglas Packer – Mayo Clinic
Understanding Cardiac Autonomic Disorders: Neurocardiogenic Syncope, Postural Orthostatic Tachycardia Syndrome and Inappropriate Sinus Tachycardia - Raghuveer Dendi — University of Kansas Hospital
Cost effective management of syncope: What works and what doesn’t? - Kathy Blake – University of New Mexico
The Role of Imaging in the Management of Cardiac Arrhythmias - Richard Fogel – St. Vincent, Medical Group
Durable Pulmonary Vein isolation – can the mission ever be accomplished? - Andre d’Avila – Mount Sinai Hospital
Are advances in energy sources, contact feedback, and other bells and whistles equal to better ablation outcomes? - David Callans – Hospital of the University of Pennsylvania
Debate: Should a patient with Primary Prevention ICD or CRT-D and Subsequent Improvement in EF >40% Get a Defibrillator at time of Elective Generator Replacement? - Sana Al-Khatib – Duke University Medical Center - Martin Emert — University of Kansas Medical Center
Subcutaneous ICDs: Why, Who and How? - Samuel Asirvatham – Mayo Clinic
Cardiac Device Infection: Intricacies in Management - Anne Gillis – University of Calgary

Content Unavailable

We apologize this content is not available at this time.

Ablation of Aflutter in CHD/ Risk stratification in CHD - Edward Rhee – Phoenix Children’s Hospita
Tools and Techniques for Successful Lead Removal – Notes from a Seasoned Extractor - Loren Berenbom — University of Kansas Medical Center
Adjunctive strategies in improving the outcomes of non-paroxsmal AF ablation - Andrea Natale – Texas Cardiac Arrhythmia Institute
Comprehensive Management of Ventricular Tachycardia Storm - David Callans – Hospital of the University of Pennsylvania
PVC Mediated Cardiomyopathy – Diagnosis and Treatment - Luigi DiBiase – Texas Cardiac Arrhythmia Institute
Epicardial VT ablation – Tips and Traps - Andre d’Avila – Mount Sinai Hospital
Role of Hemodynamic support in Complex VT/VF Ablation - Douglas Packer – Mayo Clinic

KCHRS 2019

Date

August 17-18, 2019
(Saturday to Sunday)

Venue

Sheraton Overland Park Hotel
6100 College Blvd, Overland Park, KS 66211